The share of corresponding/leading authors in scientific publications in critical care and intensive care medicine in China has been consistently high. In 2023, it stood at 99.1%. Forecasts for 2024-2028 display a marginal annual increase, with an expected value of 99.25% by 2028. This reflects a steady rise of approximately 0.1% annually. The consistent year-on-year growth underscores the dominant role of corresponding/leading authors in this field in China. The Compound Annual Growth Rate (CAGR) over this five-year span indicates minimal but assured growth.
Future trends to watch include the potential influence of international collaborations and the evolving prominence of multidisciplinary research teams, which could impact the share of corresponding/leading authors as China continues to expand its role in global scientific research.
